Volume 87, Issue 2 pp. 171-178
Free Access

Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty–virus-like particles

G. T. LAYTON

G. T. LAYTON

British Biotech Pharmaceuticals Ltd

Search for more papers by this author
S. J. HARRIS

S. J. HARRIS

British Biotech Pharmaceuticals Ltd

Search for more papers by this author
J. MYHAN

J. MYHAN

British Biotech Pharmaceuticals Ltd

Search for more papers by this author
D. WEST

D. WEST

British Biotech Pharmaceuticals Ltd

Search for more papers by this author
F. GOTCH

F. GOTCH

Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital

Search for more papers by this author
M. HILL-PERKINS

M. HILL-PERKINS

British Biotech Pharmaceuticals Ltd

Search for more papers by this author
J. S. COLE

J. S. COLE

British Biotech Pharmaceuticals Ltd

Search for more papers by this author
N. MEYERS

N. MEYERS

British Biotech Pharmaceuticals Ltd

Search for more papers by this author
S. WOODROW

S. WOODROW

British Biotech Pharmaceuticals Ltd

Search for more papers by this author
T. J. FRENCH

T. J. FRENCH

British Biotech Pharmaceuticals Ltd

Search for more papers by this author
S. E. ADAMS

S. E. ADAMS

British Biotech Pharmaceuticals Ltd

Search for more papers by this author
A. J. KINGSMAN

A. J. KINGSMAN

Department of Biochemistry, University of Oxford, Oxford, UK

Search for more papers by this author
First published: February 1996
Citations: 34
Dr G. T. Layton British Biotech Pharmaceuticals Ltd, Watlington Road, Cowley, Oxford OX4 5LY, UK.

Abstract

The induction of cytotoxic T-lymphocyte (CTL) responses to viral proteins is thought to be an essential component of protective immunity against viral infections. Methods for generating such responses in a reproducible manner would be of great value in vaccine development. We demonstrate here that the recombinant antigen-presentation system based on the yeast transposon (Ty) particle-forming p1 protein is a potent means of inducing CTL responses to a variety of viral CTL epitopes, including influenza virus nucleoprotein (two epitopes), Sendai virus and vesicular stomatitis virus nucleoproteins, and the V3 loop of human immunodeficiency virus type-1 (HIV-1) gp120. CTL were primed by hybrid Ty–virus-like particles (VLP) carrying the minimal epitope or as much as 19 000 MW of protein. Ty–VLP carrying two different epitopes (dual-epitope Ty–VLP) were capable of priming CTL responses in two different strains of mice or against two epitopes in the same individual. Furthermore, co-administration of a mixture of two different Ty–VLP carrying single epitopes could induce responses to both epitopes in the same individual. Ty–VLP appear to represent a reproducible and flexible system for inducing CTL responses in mice, and warrant further evaluation in primates.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.